Milestone Scientific (MLSS) risk factors
Item 1A of every Milestone Scientific Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors42 risks11 new6 dropped21 reworded
Cash burn of $2.9M continues, driving going concern doubts with only $1.1M in cash remaining. Tariffs on components sourced from China and reliance on the CompuFlo Epidural System shape core risks. NYSE American listing compliance and cybersecurity threats to connected medical devices are highlighted.
Filed Mar 31, 2026 - FY2024 10-K risk factors37 risks
Milestone Scientific faces significant operating losses and ongoing cash burn, requiring additional funding and equity dilution risks. The company relies heavily on single suppliers in China and the US, alongside international sales. Regulatory oversight, patent protection, and market adoption of the CompuFlo system are critical vulnerabilities.
Filed Apr 15, 2025